GENEVA, Aug. 10 -- ASSEMBLY MEDICINE, LLC. (2-3F, Bldg. 1, No. 88 Da'erwen Rd.Pudong New Area, Shanghai 201203), 安升(上海)医药科技有限公司 (中国上海市浦东新区达尔文路88号1幢2-3层) filed a patent application (PCT/CN2025/073392) for "SINGLE-DOMAIN ANTIBODY TARGETING TFR1 AND USE THEREOF" on Jan 20, 2025. With publication no. WO/2025/162031, the details related to the patent application was published on Aug 07, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual...